Search

Coloplast A-S (Class B)

Avatud

597.4 0.88

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

588.6

Max

596

Põhinäitajad

By Trading Economics

Sissetulek

-107M

805M

Müük

28M

7B

P/E

Sektori keskmine

31.544

36.442

Aktsiakasum

4.93

Dividenditootlus

3.89

Kasumimarginaal

11.569

Töötajad

16,814

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+11.86% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

3.89%

3.00%

Järgmine tulemuste avaldamine

4. nov 2025

Turustatistika

By TradingEconomics

Turukapital

-9.4B

127B

Eelmine avamishind

596.52

Eelmine sulgemishind

597.4

Coloplast A-S (Class B) Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

21. okt 2025, 23:55 UTC

Kuumad aktsiad

Stocks to Watch: DraftKings, Texas Instruments, Intuitive Surgical, Pegasystems

21. okt 2025, 23:49 UTC

Tulu

Texas Instruments Warns of Slower Semiconductor Industry Recovery -- Update

21. okt 2025, 21:40 UTC

Tulu

Waste Connections 3Q Revenue Rises

21. okt 2025, 21:14 UTC

Tulu
Suurimad hinnamuutused turgudel

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth -- Update

21. okt 2025, 21:05 UTC

Omandamised, ülevõtmised, äriostud

GE Vernova to Acquire Full Stake in Prolec GE Joint Venture

21. okt 2025, 20:57 UTC

Omandamised, ülevõtmised, äriostud

DraftKings to Launch Prediction Markets Platform

21. okt 2025, 20:38 UTC

Tulu

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth

21. okt 2025, 20:35 UTC

Tulu

Capital One 3Q Sales, Profit Jump

21. okt 2025, 20:32 UTC

Tulu

Texas Instruments 3Q Revenue Up on Growth Across End Markets

21. okt 2025, 23:44 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

21. okt 2025, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen, Hopes for Takaichi's Econ Steps -- Market Talk

21. okt 2025, 23:39 UTC

Market Talk

Gold Consolidates; May Undergo Further Technical Correction -- Market Talk

21. okt 2025, 23:36 UTC

Market Talk

BHP Has Hidden Leverage to Gold's Rush -- Market Talk

21. okt 2025, 22:55 UTC

Omandamised, ülevõtmised, äriostud

Scentre Says This Forms Part of Capital Management Strategy

21. okt 2025, 22:55 UTC

Omandamised, ülevõtmised, äriostud

Scentre: Continues to Evaluate Strategic Opportunities Including New JV Partners

21. okt 2025, 22:54 UTC

Omandamised, ülevõtmised, äriostud

Scentre Notes Media Report on Possible Sale of Stake in Westfield Chermside to Dexus Fund

21. okt 2025, 21:09 UTC

Market Talk
Tulu

Netflix Creators Have Started Using AI in Production -- Market Talk

21. okt 2025, 20:58 UTC

Market Talk
Tulu

Netflix Aims to Build on 'KPop Demon Hunters' Mania -- Market Talk

21. okt 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

21. okt 2025, 20:50 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Financial Services Roundup: Market Talk

21. okt 2025, 20:43 UTC

Tulu

Netflix Stock Drops After Earnings Miss Estimates -- Barrons.com

21. okt 2025, 20:41 UTC

Tulu

Dow Industrials Hit Record, Boosted by Strong Earnings -- WSJ

21. okt 2025, 20:33 UTC

Omandamised, ülevõtmised, äriostud

GE Vernova: Deal Accelerates Growth for Electrification Segment >GEV

21. okt 2025, 20:33 UTC

Omandamised, ülevõtmised, äriostud

GE Vernova Acquiring Remaining 50% Stake of JV From Xignux >GEV

21. okt 2025, 20:32 UTC

Omandamised, ülevõtmised, äriostud

GE Vernova: Prolec GE Expects Low Double-Digit Rev Growth in Coming Years >GEV

21. okt 2025, 20:32 UTC

Omandamised, ülevõtmised, äriostud

GE Vernova: Prolec GE Expects $3B in Rev at 25% Adj EBITDA Margin in 2025 >GEV

21. okt 2025, 20:32 UTC

Omandamised, ülevõtmised, äriostud

GE Vernova: $5.275B Purchase Price at Closing, Expected to Be Funded Equally With Cash & Debt >GEV

21. okt 2025, 20:32 UTC

Omandamised, ülevõtmised, äriostud

GE Vernova Will Acquire Remaining 50% Stake of Prolec GE >GEV

21. okt 2025, 20:31 UTC

Omandamised, ülevõtmised, äriostud

GE Vernova To Fully Acquire Prolec GE Joint Venture >GEV

21. okt 2025, 20:29 UTC

Tulu

Northrop Stock Tumbles on Sales Disappointment. When Good Isn't Good Enough. -- Barrons.com

Coloplast A-S (Class B) Prognoos

Hinnasiht

By TipRanks

11.86% tõus

12 kuu keskmine prognoos

Keskmine 901.38 DKK  11.86%

Kõrge 1,056 DKK

Madal 720 DKK

Põhineb 8 Wall Streeti analüütiku instrumendi Coloplast A-S (Class B) 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

8 ratings

2

Osta

4

Hoia

2

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat